SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
Viking Therapeutics, Inc.
@VKTX_InsiderForm 4 Filing: Lian Brian Sells $4.9M of $VKTX
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Viking Therapeutics, Inc.
Ticker: $VKTX
Transaction Value
$4.9M
Price/Share: $13.37
transaction date
2026-07-29
Shares: 370,184
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Lian Brian, holds the title of President & CEO at Viking Therapeutics, Inc..
On 2026-07-29, the insider transacted 370,184 shares.The shares were transacted at a weighted average price of $13.37 per share, resulting in a total market-relevant value of $4.9M.
Executive Summary Summary
Lian Brian (President & CEO) sold $4.9M of $VKTX
Post-Transaction Position: 2,572,441 shares
SEC Accession No: 0001193125-26-324448 (CIK: 1614578)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.